Opportunities and challenges in the Life Sciences and Healthcare circuit

Zhang Suyang mentioned that because it is closely related to everyone's life, the life science and medical health circuit is largely subject to ethical constraints. In addition, due to the large investment in the life sciences and healthcare circuit, there may be constraints on the pricing system.

Beyond that, the life sciences and healthcare circuit has few other constraints, and companies can push the boundaries as far as they can by virtue of their capabilities.

With the recovery of the market, the capital market is now also eager to invest in high-quality projects in the life science and medical health track. So what abilities and characteristics do investors value more when raising funds?

Zhang Suyang believes that when an enterprise enters the growth stage, investors are usually very concerned about the completion of the enterprise's products, as well as sales and profits, in order to judge the future development potential of the enterprise.

In addition, in judging the ability of entrepreneurs, investors are also concerned about the past experience of entrepreneurs, such as whether there is successful experience. In the field of segmentation, investors prefer the invested enterprises to be the top two in the industry, and it is best to be the "leader" in the industry, which requires a certain innovation ability and the matching of team capabilities.

Chen Penghui added that in addition to focusing on the revenue and profit of the enterprise, investors also have two angles to judge the quality of the project.

One perspective is to see whether the product can really be listed, and the future commercialization; Another perspective is that the team should be complete, not rely on one or two people to fight alone, but the enterprise from the CEO to the middle level of cadres, grass-roots executives to form a complete system. If the enterprise can meet the standards in these two dimensions, it can be regarded as a high-quality growth enterprise.